Paper40838416
The NEAT1/miR-124-3p/CCL2 axis in chronic kidney disease progression: integrated bioinformatics analysis and experimental validation.
Chen G and 6 others. Epigenomics, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. The NEAT1/miR-124-3p/CCL2 axis in chronic kidney disease progression: integrated bioinformatics analysis and experimental validation. Papers, record 40838416. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40838416
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The NEAT1/miR-124-3p/CCL2 axis in chronic kidney disease progression: integrated bioinformatics analysis and experimental validation.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Renal Insufficiency, Chronic | Major topic |
| RNA, Long Noncoding | Major topic |
| MicroRNAs | Major topic |
| Chemokine CCL2 | Major topic |
| Humans | |
| Computational Biology | |
| Disease Progression | |
| Biomarkers | |
| Epithelial-Mesenchymal Transition | |
| Gene Regulatory Networks | |
| Protein Interaction Maps |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32651223 | Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury. | J Am Soc Nephrol | 2020 | https://conductscience.org/library/papers/32651223 | PubMed |
| 2 | 39643696 | Crosstalk between glomeruli and tubules. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/39643696 | PubMed |
| 3 | 35934136 | Angiopoietin-2 inhibition attenuates kidney fibrosis by hindering chemokine C-C motif ligand 2 expression and apoptosis of endothelial cells. | Kidney Int | 2022 | https://conductscience.org/library/papers/35934136 | PubMed |
| 4 | 37872392 | Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p/ITGB1 axis. | Sci Rep | 2023 | https://conductscience.org/library/papers/37872392 | PubMed |
| 5 | 39088708 | Long Non-coding RNA NEAT1 , NOD-Like Receptor Family Protein 3 Inflammasome, and Acute Kidney Injury. | J Am Soc Nephrol | 2024 | https://conductscience.org/library/papers/39088708 | PubMed |
| 6 | 35619557 | Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5p. | Mol Ther | 2022 | https://conductscience.org/library/papers/35619557 | PubMed |
| 7 | 34715574 | miR-124-3p relieves allergic rhinitis by inhibiting dipeptidyl peptidase-4. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/34715574 | PubMed |
| 8 | 36440854 | LncRNA NEAT1 accelerates renal fibrosis progression via targeting miR-31 and modulating RhoA/ROCK signal pathway. | Am J Physiol Cell Physiol | 2023 | https://conductscience.org/library/papers/36440854 | PubMed |
| 9 | 39098910 | Long non-coding RNA NEAT1 induced by BHLHE40 activates Wnt/β-catenin signaling and potentiates colorectal cancer progression. | Cell Div | 2024 | https://conductscience.org/library/papers/39098910 | PubMed |
| 10 | 30515796 | Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30515796 | PubMed |
| 11 | 34322395 | Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review. | Front Oncol | 2021 | https://conductscience.org/library/papers/34322395 | PubMed |
| 12 | 36242511 | NEAT1 Regulates Calcium Oxalate Crystal-Induced Renal Tubular Oxidative Injury via miR-130/IRF1. | Antioxid Redox Signal | 2023 | https://conductscience.org/library/papers/36242511 | PubMed |
| 13 | 35153075 | The potential of long noncoding RNA therapies. | Trends Pharmacol Sci | 2022 | https://conductscience.org/library/papers/35153075 | PubMed |
| 14 | 35364751 | LncRNA NEAT1 knockdown ameliorates LPS-induced human kidney injury by mediating the miR-330-5p/FOXO3 axis. | Int Urol Nephrol | 2022 | https://conductscience.org/library/papers/35364751 | PubMed |
| 15 | 33459955 | Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa. | Int Urol Nephrol | 2021 | https://conductscience.org/library/papers/33459955 | PubMed |
| 16 | 29127220 | Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD. | Physiol Genomics | 2018 | https://conductscience.org/library/papers/29127220 | PubMed |
| 17 | 35531954 | MicroRNAs in kidney development and disease. | JCI Insight | 2022 | https://conductscience.org/library/papers/35531954 | PubMed |
| 18 | 32500512 | Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells. | J Physiol Biochem | 2020 | https://conductscience.org/library/papers/32500512 | PubMed |
| 19 | 32054986 | Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/32054986 | PubMed |
| 20 | 34871811 | MicroRNA expression profiling in acute kidney injury. | Transl Res | 2022 | https://conductscience.org/library/papers/34871811 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41891957 | Multifaceted roles of miR‑124 in cancer: Molecular mechanisms and clinical prospects (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/41891957 |
Source PubMed
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL2 | 6347 | PubTator's text mining | https://conductscience.org/library/genes/6347 | NCBI Gene |
| CXCL1 | 2919 | PubTator's text mining | https://conductscience.org/library/genes/2919 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| MIR124-3 | 406909 | PubTator's text mining | https://conductscience.org/library/genes/406909 | NCBI Gene |
| MMP7 | 4316 | PubTator's text mining | https://conductscience.org/library/genes/4316 | NCBI Gene |
| NEAT1 | 283131 | PubTator's text mining | https://conductscience.org/library/genes/283131 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| VCAN | 1462 | PubTator's text mining | https://conductscience.org/library/genes/1462 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40838416
GET https://conductscience.org/api/papers/v1/40838416/references?page=2